Cannabis Watch Archives | Email alerts

Feb. 26, 2019, 6:58 a.m. EST

Cronos falls, Aurora gains after wave of pot-stock initiations

Jefferies analyst labels Aurora and Canopy the best bets to dominate cannabis sector, Cronos and Hexo get ‘sell’ ratings

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Aurora Cannabis Inc. (ACB)
  • X
    Aurora Cannabis Inc. (ACB)

or Cancel Already have a watchlist? Log In

By Jeremy C. Owens, MarketWatch


Bloomberg News/Landov
Hexo Corp., which owns the greenhouse pictured above, was one of two pot companies to receive a “sell” rating in a batch of initiations from Jefferies & Co. released Monday morning.

Cannabis stocks fell overall Monday, after Jefferies & Co. jumped into the sector with initiations of nine pot producers and called Aurora Cannabis Inc. and Canopy Growth Corp. the cream of the cannabis crop.

Overall, Jefferies labeled five of the companies a buy: Aurora /zigman2/quotes/210559470/composite ACB -1.90%   /zigman2/quotes/203734337/delayed CA:ACB -2.25%  , CannTrust Holdings Inc.    , Organigram Holdings Inc. /zigman2/quotes/202287350/delayed CA:OGI -0.44%  , Green Organic Dutchman Holdings Ltd. /zigman2/quotes/206870535/delayed CA:TGOD 0.00%   /zigman2/quotes/204266798/delayed TGODF +2.25%   and Flowr Corp. /zigman2/quotes/205237089/delayed FLWPF +0.14% . Two companies received hold ratings — Canopy /zigman2/quotes/200603886/composite CGC +1.06%   /zigman2/quotes/202205609/delayed CA:WEED +0.71%  and Emerald Health Therapeutics Inc. /zigman2/quotes/206111957/delayed CA:EMH 0.00%   — while Cronos Group Inc. /zigman2/quotes/206842762/composite CRON +2.39%   /zigman2/quotes/202715342/delayed CA:CRON +1.89%  and Hexo Corp. /zigman2/quotes/206508254/composite HEXO -0.37%   /zigman2/quotes/200008967/delayed CA:HEXO -2.11%   were labeled as “underperform,” the equivalent of a sell rating.

Bennett wrote that Aurora, which received a $12 price target, and Canopy, which was initiated with a $64 price target, are the “best placed to dominate on a global basis in the years ahead.” Canopy’s hold rating was based on his opinion that the market’s valuation “has appropriately captured this strong positioning,” but he sees room for growth in Aurora. He especially likes how the company has positioned itself to eventually enter the U.S. market, which he believes is “yet to be fully appreciated” by the market.

See also: Canopy Growth co-CEO reveals top priorities for world’s largest legal marijuana company

“The U.S. is the world’s biggest cannabis market,” Bennett wrote in a piece on the entire sector, while noting that cannabis is still federally illegal on the federal level and all pot companies can do is position themselves for a U.S. entry. “If any cannabis co. wants to claim large cap or even megacap future status, they need to have a strong position in the U.S.”

Cronos shares had the biggest move of the bunch Monday, falling more than 7%. Jefferies analyst Owen Bennett wrote that he has “not been overly impressed” with the company’s early performance in the Canadian recreational-marijuana sales market.

/zigman2/quotes/206842762/composite CRON 5.68, +0.13, +2.39%

“Flower capacity could be limiting, its main recreational brand has a questionable target audience in our view, early consumer reviews of said brand do not stand out, and little infrastructure appears to be in place for the derivative market, even with the Altria /zigman2/quotes/208895754/composite MO -0.80%  support,” Bennett wrote while giving Cronos a $17 price target. Bennett did say that Cronos is positioned well in the medical-marijuana market, especially overseas.

Bennett was harsher on Hexo, specifically calling out its deal with Molson Coors Brewing Co. /zigman2/quotes/205165133/composite TAP +0.24%  .

“We think there’s a tendency by the market, due to limited financial metrics/industry data, to take any CPG/brand partnership as a validation of a superior business; the deal Hexo signed with Molson is an example,” Bennett wrote. “The reality is Molson didn’t put any capital in, we don’t actually know if Hexo have superior patented water soluble applications to commercialize near term, no current bottling infrastructure appears in place, and we’ve no idea about their extraction capacity to supply the beverages.”

Read: How marijuana companies can profit without selling pot

The CannTrust rating arrived as the pot producer’s shares began trading Tuesday morning on the New York Stock Exchange under the symbol CTST  . Bennett said the listing “could drive attractive 12-month re-rating as more large investors become aware of the story.”

Medical-marijuana company GW Pharmaceuticals Holdings PLC /zigman2/quotes/209686240/composite GWPH +0.19%  is scheduled to report quarterly earnings Tuesday. Reporting later this week are MedMen Enterprises Inc. /zigman2/quotes/201940908/delayed MMNFF +1.97%  and Green Growth Brands Inc. /zigman2/quotes/204912440/delayed GGBXF +5.80%  , which is making a hostile bid for Aphria Inc. /zigman2/quotes/207425803/composite APHA +0.34%   /zigman2/quotes/205566616/delayed CA:APHA -0.17%  .

Overall, the sector was down in Monday trading, with the Horizons Marijuana Life Sciences /zigman2/quotes/208856346/delayed CA:HMMJ 0.00%  declining 0.9% and the ETFMG Alternative Harvest ETF /zigman2/quotes/204332491/composite MJ +0.63%  falling 1.1%.

Correction: An earlier version of this article had an inaccurate earnings date for GW Pharmaceuticals PLC due to an error from a third-party data provider. The article has been updated.

/zigman2/quotes/210559470/composite
US : U.S.: NYSE
$ 9.83
-0.19 -1.90%
Volume: 1.22M
Aug. 12, 2020 11:17a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.13 billion
Rev. per Employee
$94,401
loading...
/zigman2/quotes/203734337/delayed
CA : Canada: Toronto
$ 13.05
-0.30 -2.25%
Volume: 624,437
Aug. 12, 2020 11:02a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.51 billion
Rev. per Employee
$123,163
loading...
/zigman2/quotes/202287350/delayed
CA : Canada: TSX Venture
$ 6.85
-0.03 -0.44%
Volume: 392,662
Aug. 21, 2019 4:00p
P/E Ratio
31.08
Dividend Yield
N/A
Market Cap
$1.07 billion
Rev. per Employee
$64,794
loading...
/zigman2/quotes/206870535/delayed
CA : Canada: Toronto
$ 0.44
0.00 0.00%
Volume: 222,861
Aug. 12, 2020 10:59a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$169.23 million
Rev. per Employee
$10,924
loading...
/zigman2/quotes/204266798/delayed
US : U.S.: OTC
$ 0.33
+0.0073 +2.25%
Volume: 164,002
Aug. 12, 2020 11:02a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$127.24 million
Rev. per Employee
$8,428
loading...
/zigman2/quotes/205237089/delayed
US : U.S.: OTC
$ 0.36
+0.0005 +0.14%
Volume: 2,072
Aug. 12, 2020 10:59a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$43.66 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/200603886/composite
US : U.S.: NYSE
$ 17.13
+0.18 +1.06%
Volume: 1.71M
Aug. 12, 2020 11:17a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$6.30 billion
Rev. per Employee
$115,039
loading...
/zigman2/quotes/202205609/delayed
CA : Canada: Toronto
$ 22.72
+0.16 +0.71%
Volume: 615,856
Aug. 12, 2020 11:02a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$8.37 billion
Rev. per Employee
$150,142
loading...
/zigman2/quotes/206111957/delayed
CA : Canada: TSX Venture
$ 0.18
0.00 0.00%
Volume: 78,258
Aug. 12, 2020 10:31a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$36.03 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/206842762/composite
US : U.S.: Nasdaq
$ 5.68
+0.13 +2.39%
Volume: 1.36M
Aug. 12, 2020 11:17a
P/E Ratio
12.40
Dividend Yield
N/A
Market Cap
$1.94 billion
Rev. per Employee
$55,248
loading...
/zigman2/quotes/202715342/delayed
CA : Canada: Toronto
$ 7.53
+0.14 +1.89%
Volume: 357,771
Aug. 12, 2020 11:01a
P/E Ratio
12.72
Dividend Yield
N/A
Market Cap
$2.59 billion
Rev. per Employee
$70,780
loading...
/zigman2/quotes/206508254/composite
US : U.S.: NYSE
$ 0.70
-0.0026 -0.37%
Volume: 3.17M
Aug. 12, 2020 11:17a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$291.86 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/200008967/delayed
CA : Canada: Toronto
$ 0.93
-0.02 -2.11%
Volume: 506,985
Aug. 12, 2020 10:58a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$388.18 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/208895754/composite
US : U.S.: NYSE
$ 43.25
-0.35 -0.80%
Volume: 1.91M
Aug. 12, 2020 11:17a
P/E Ratio
N/A
Dividend Yield
7.93%
Market Cap
$81.03 billion
Rev. per Employee
$2.36M
loading...
/zigman2/quotes/205165133/composite
US : U.S.: NYSE
$ 38.30
+0.09 +0.24%
Volume: 460,123
Aug. 12, 2020 11:17a
P/E Ratio
N/A
Dividend Yield
0.00%
Market Cap
$8.32 billion
Rev. per Employee
$606,738
loading...
/zigman2/quotes/209686240/composite
US : U.S.: Nasdaq
$ 110.00
+0.20 +0.19%
Volume: 119,423
Aug. 12, 2020 11:17a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$3.41 billion
Rev. per Employee
$20,686
loading...
/zigman2/quotes/201940908/delayed
US : U.S.: OTC
$ 0.18
+0.0035 +1.97%
Volume: 521,981
Aug. 12, 2020 11:01a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$109.32 million
Rev. per Employee
$49,729
loading...
/zigman2/quotes/204912440/delayed
US : U.S.: OTC
$ 0.03
+0.0015 +5.80%
Volume: 154,703
Aug. 12, 2020 10:31a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$4.48 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207425803/composite
US : U.S.: Nasdaq
$ 4.47
+0.01 +0.34%
Volume: 1.59M
Aug. 12, 2020 11:17a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.29 billion
Rev. per Employee
$147,410
loading...
/zigman2/quotes/205566616/delayed
CA : Canada: Toronto
$ 5.93
-0.01 -0.17%
Volume: 927,557
Aug. 12, 2020 11:02a
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.71 billion
Rev. per Employee
$190,843
loading...
/zigman2/quotes/208856346/delayed
CA : Canada: Toronto
$ 6.76
0.00 0.00%
Volume: 37,162
Aug. 12, 2020 11:01a
loading...
/zigman2/quotes/204332491/composite
US : U.S.: NYSE Arca
$ 12.74
+0.08 +0.63%
Volume: 262,846
Aug. 12, 2020 11:17a
loading...

Jeremy Owens is MarketWatch’s technology editor and San Francisco bureau chief. You can follow him on Twitter @jowens510.

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.